M19-072
ClinicalTrials.gov NCT03941964
Research payments
$948,161
Through program year 2020, $948,161 in research payments was reported against M19-072, across 82 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT03941964
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $948,161 | 82 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- John Renshaw San Antonio, TX Named on 9 payments
- Habte Yimer Tyler, TX Named on 9 payments
- Sudhir Manda Tucson, AZ Named on 8 payments
- John Burke Aurora, CO Named on 8 payments
- Edward Broun Cincinnati, OH Named on 7 payments
- Timothy Larson Minneapolis, MN Named on 6 payments
- Jason Melear Austin, TX Named on 6 payments
- Bertrand Anz Chattanooga, TN Named on 5 payments
- Jeff Sharman Stanford, CA Named on 5 payments
- William Donnellan Nashville, TN Named on 5 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.